Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder

Premenstrual dysphoric disorder (PMDD) is estimated to affect 3%–8% of reproductive age women. Multiple therapeutic modalities have been evaluated with varying efficacy for the associated somatic and mood symptoms. The majority of older studies had shown that oral contraceptive pills (OCs) were most...

Descripción completa

Detalles Bibliográficos
Autores principales: Breech, Lesley L, Braverman, Paula K
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971718/
https://www.ncbi.nlm.nih.gov/pubmed/21072278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971718/
https://www.ncbi.nlm.nih.gov/pubmed/21072278

Ejemplares similares